Research Study: CBD Gummies Market Worth $13.9 Billion By 2028
Written by Sara James
The global CBD Gummies Market size is expected to reach USD 13.9 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 30.7% from 2021 to 2028. The exceptional medicinal properties without any harmful side effects are expected to be a major factor contributing to the growth of the market. The consumption of CBD (Cannabidiol) gummies to relieve anxiety, depression, pain, and inflammation, and to induce sleep is expected to boost the growth of the market.
The 2018 U.S. Farm Bill is considered to be one of the most supportive government policies for the promotion of CBD gummies and other CBD-based products in the U.S. The bill legalizes hemp and hemp-based products in the country and omits hemp from the definition of marijuana in sectio 102(16) of the Controlled Substances Act. As per this bill, the USDA will approve the states before harvesting for monitoring and production regulating purposes.
In addition to this, a few favorable changes in the overall regulations on hemp are promoting the supply of various CBD-based products in the U.S. market. For instance, under the 2018 Farm Bill, hemp has been removed from the Controlled Substances Act (CSA), which implies that cannabis plants and derivatives that constitute less than or equal to 0.3% dry weight THC are no longer controlled substances under federal law.
These aforementioned supportive policies are anticipated to boost the demand for CBD gummies in the U.S. market. The market, however, is still at a nascent stage and the products being launched are only in the countries where CBD-based edible products are legalized. Manufacturers are, however, expecting a significant shift in product positioning in the global market, with the hopes that CBD oil and gummies will become as common as fish oil or multivitamin gummies.
Related Press Release@ CBD Gummies Market Report
CBD Gummies Market Report Highlights
- By concentration, the low concentrated CBD gummies held the largest share of 90.2% in 2020 and are expected to maintain their lead over the forecast period. First-time buyers of CBD gummies prefer low CBD content gummies ranging from 1 mg to 20 mg CBD per gummy
- High CBD concentrated gummies are projected to register the fastest CAGR of 34.7% from 2021 to 2028. The increasing awareness among consumers regarding the advantages of marijuana edibles for the treatment of sleep disorders is anticipated to fuel the segment growth in the near future
- The offline distribution channel was the largest segment with a share of 56.4% in 2020. The overall sales through offline channel dropped drastically owing to the closure of all the brick and mortar stores due to the pandemic across the globe
- North America held the largest share of 62.0% in 2020. In the U.S., the legalization of cannabis for medical and recreational purposes is among the top factors driving the market for CBD gummies
Article author
About the Author
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Further reading
Further Reading
Article
Fear of Being Healthy?
Why do some people have trouble addressing health concerns?
October 8, 2026
Article
Why General Practice Accreditation Delivers Real Value Beyond Compliance
General practice accreditation is more than a compliance requirement. This article explains how accreditation supports patient safety, quality improvement, practice governance, funding eligibility, and ongoing trust in Australia’s healthcare system.
October 8, 2026
Website
HealthNexo
HealthNexo provides trustworthy, evidence-based health information and the latest health news. We cover disease prevention, diagnosis, nutrition, fitness, and wellness to help you make informed decisions for a healthier life.
October 2, 2026
Article
Dengue Diagnosis: Which Blood Tests Are Used and When?
Dengue diagnosis blood tests include RT-PCR/NAAT, NS1, IgM, IgG, and CBC. Early tests detect the virus, while IgM becomes more useful later. CBC helps monitor the patient but cannot confirm dengue alone.
October 2, 2026